Skip to content

Evaluation of acetaminophen injection in preventing severe rebound pain after regional nerve block block resolution: a prospective randomized, double-blind, placebo-controlled study

Evaluation of acetaminophen injection in preventing severe rebound pain after regional nerve block block resolution: a prospective randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086664
Enrollment
Unknown
Registered
2024-07-08
Start date
2024-07-14
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe rebound pain

Interventions

Acetaminophen group :500mg of acetaminophen injection was administered at the end of surgery and 6 hours postoperatively, respectively
saline group:Administer the same volume of normal saline at the same time

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Patients between 18 and 60 yr of age. (2)Patients undergoing elective arthroscopic knee surgery under spinal anesthesia. (3)ASA I–III. (4)Voluntarily participate in this study and sign a written informed consent form

Exclusion criteria

Exclusion criteria: (1) Allergy to acetaminophen; (2) Liver function impairment is defined as levels of alanine aminotransferase and/or aspartate aminotransferase exceeding the upper limit of the normal range by more than 2 times, or total bilirubin being at least 1.5 times the upper limit of the normal range; (3) Renal insufficiency, defined as creatinine range>176umol/L; (4) Uncontrolled hypertension or diabetes; (5) Other situations determined by the researcher to be unsuitable for selection.

Design outcomes

Primary

MeasureTime frame
The incidence of rebound pain within 24 hours after surgery;

Secondary

MeasureTime frame
VAS pain score;Duration of nerve block;Use of analgesic drugs;QoR-15 rating;sleep quality;

Countries

China

Contacts

Public ContactRili Yu; Liao Qin

The Third Xiangya Hospital of Central South University

yurili33@163.com+86 136 0743 3749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026